0001209191-15-004435.txt : 20150115 0001209191-15-004435.hdr.sgml : 20150115 20150115164823 ACCESSION NUMBER: 0001209191-15-004435 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150113 FILED AS OF DATE: 20150115 DATE AS OF CHANGE: 20150115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 15530401 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-13 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Corp Controller Common Stock 2015-01-13 4 M 0 1125 51.75 A 15312 D Common Stock 2015-01-13 4 S 0 425 120.61 D 14887 D Common Stock 2015-01-13 4 S 0 300 122.28 D 14587 D Common Stock 2015-01-13 4 S 0 400 123.05 D 14187 D Common Stock 169 I 401(k) Stock Option (right to buy) 51.75 2015-01-13 4 M 0 1125 0.00 D 2021-07-12 Common Stock 1125 2250 D Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $120.61 (range $120.36 to $120.93). Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $122.28 (range $121.83 to $122.62). Open market sales reported on this line occurred at a weighted average price of $123.05 (range $122.87 to $123.57). The option vests in 16 quarterly installments from 07/13/2011. Omar White, Attorney-In-Fact 2015-01-15